Home / Markets / News / Laurus Labs extends fall for fourth straight day, dips 21% from record high

Laurus Labs extends fall for fourth straight day, dips 21% from record high

The company's profit after tax (PAT) was up 328 per cent year-on-year (YoY) at Rs 242 crore.

paracetamol, pharma, drugs, medicine, health

Premium

Revenues grew 60 per cent YoY to Rs 1,139 crore on the back of strong growth across segments.

3 min read Last Updated : Nov 04 2020 | 2:38 PM IST

Shares of Laurus Labs were trading lower for the fourth straight day on Wednesday. The stock slipped 7 per cent to Rs 271 on the BSE in the intra-day trade. With today’s decline, the stock of the pharmaceutical company has slumped 21 per cent from its record high level of Rs 345, touched on October 30, 2020, in intra-day trade.

Laurus Labs was down on profit booking after the company reported a robust set of July-September quarter (Q2FY21) numbers. The company’s profit after tax (PAT) was up 328 per cent year-on-year (YoY) at Rs 242 crore for the quarter on

Topics : Laurus Labs Buzzing stocks Markets S&P BSE Sensex

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in